To Dissect or Not to Dissect? The Surgeon’s Perspective on the Prediction of Greater Than or Equal to 4 Axillary Lymph Node Metastasis in Early-Stage Breast Cancer: A Comparative Analysis of the Per-Protocol Population of the SINODAR-ONE Clinical Trial
Saved in:
Main Authors: | Corrado Tinterri, MD, Giuseppe Canavese, MD, Damiano Gentile, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2024-03-01
|
Series: | Annals of Surgery Open |
Online Access: | http://journals.lww.com/10.1097/AS9.0000000000000405 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
by: Wil L. Santivasi, et al.
Published: (2014-01-01) -
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
by: Brian Hu, et al.
Published: (2018-01-01) -
Robotic-Assisted Dissection of Bulky Lymph Nodes in Cervical Cancer
by: Ahmet Göçmen, et al.
Published: (2014-01-01) -
Role of Absorbable Polysaccharide Hemostatic Powder in the Prevention of Complications After Axillary Lymph Node Dissection in Breast Cancer Patients: A Multicenter Retrospective Analysis
by: Simona Parisi, et al.
Published: (2025-01-01) -
Sense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
by: Anthony Van Baelen, et al.
Published: (2012-01-01)